Developments in Biological Standardization, Volumes 72-73Karger, 1990 - Biological products |
Contents
Session I | 17 |
Immunopathogene | 30 |
J Issel J M McManus S D Hagius L D Foil WV Adams Jr and R C Montelaro Baton | 49 |
Copyright | |
30 other sections not shown
Other editions - View all
Common terms and phrases
acellular acellular pertussis vaccine acellular vaccine activity amino acid animals anti-FHA anti-PT antigen APDT Apocp assay bacterial Basel biol Biological blood Bordetella pertussis bovine cats challenge clinical clones culture detected dilution disease dose efficacy EIAV ELISA epitopes equine infectious anemia experimental expression feline FeLV gene genetic genome glycoprotein HTLV-IIIB human immune responses immunodeficiency virus immunogenicity inactivated incubated induced infection inhibition inoculation isolated Japan Karger laboratory lentivirus lymphocytes MAbs macaques macrophages mice molecular monkeys monoclonal antibodies mouse mutations neutralization Osaka parapertussis pathogenic patients peptide pertussis toxin potency preparations production protective protein purified reactions recombinant replication retroviruses samples Sato sequence sera serum simian specific Standard strain subunit Table tion titer toxoid transcription viral Virol viruses visna virus vitro vivo whole cell vaccine whooping cough